Payments to Acquire Property, Plant, and Equipment of Nurix Therapeutics, Inc. from 30 Nov 2019 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Nurix Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 30 Nov 2019 to 30 Nov 2025.
  • Nurix Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 28 Feb 2025 was $3,485,000, a 21% increase year-over-year.
  • Nurix Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $14,002,000, a 51% increase from 2024.
  • Nurix Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $9,273,000, a 10% increase from 2023.
  • Nurix Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $8,401,000, a 31% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $14,002,000 +$4,729,000 +51% 01 Dec 2024 30 Nov 2025 10-K 28 Jan 2026 2025 FY
2024 $9,273,000 +$872,000 +10% 01 Dec 2023 30 Nov 2024 10-K 28 Jan 2026 2025 FY
2023 $8,401,000 -$3,843,000 -31% 01 Dec 2022 30 Nov 2023 10-K 28 Jan 2026 2025 FY
2022 $12,244,000 +$6,583,000 +116% 01 Dec 2021 30 Nov 2022 10-K 28 Jan 2025 2024 FY
2021 $5,661,000 +$1,108,000 +24% 01 Dec 2020 30 Nov 2021 10-K 09 Feb 2023 2022 FY
2020 $4,553,000 +$2,902,000 +176% 01 Dec 2019 30 Nov 2020 10-K 28 Jan 2022 2021 FY
2019 $1,651,000 01 Dec 2018 30 Nov 2019 10-K 28 Jan 2022 2021 FY

Nurix Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,485,000 +$601,000 +21% 01 Dec 2024 28 Feb 2025 10-Q 08 Apr 2025 2025 Q1
Q1 2024 $2,884,000 +$607,000 +27% 01 Dec 2023 29 Feb 2024 10-Q 08 Apr 2025 2025 Q1
Q1 2023 $2,277,000 -$1,195,000 -34% 01 Dec 2022 28 Feb 2023 10-Q 10 Apr 2024 2024 Q1
Q1 2022 $3,472,000 +$2,629,000 +312% 01 Dec 2021 28 Feb 2022 10-Q 13 Apr 2023 2023 Q1
Q1 2021 $843,000 +$479,000 +132% 01 Dec 2020 28 Feb 2021 10-Q 08 Apr 2022 2022 Q1
Q1 2020 $364,000 01 Dec 2019 29 Feb 2020 10-Q 13 Apr 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.